Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) FCF Margin: 2023-2025

Historic FCF Margin for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -3,265.59%.

  • Upstream Bio's FCF Margin fell 96543.00% to -3,265.59% in Q3 2025 from the same period last year, while for Sep 2025 it was -4,376.74%, marking a year-over-year decrease of 185431.00%. This contributed to the annual value of -2,518.27% for FY2024, which is 91869.00% down from last year.
  • Latest data reveals that Upstream Bio reported FCF Margin of -3,265.59% as of Q3 2025, which was up 22.02% from -4,187.73% recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's FCF Margin ranged from a high of -1,575.69% in Q2 2024 and a low of -7,272.97% during Q1 2025.
  • Moreover, its 3-year median value for FCF Margin was -3,247.56% (2024), whereas its average is -3,519.47%.
  • In the last 5 years, Upstream Bio's FCF Margin soared by 35,047bps in 2024 and then crashed by 452,891bps in 2025.
  • Over the past 3 years, Upstream Bio's FCF Margin (Quarterly) stood at -3,580.00% in 2023, then spiked by 35,047bps to -3,229.53% in 2024, then tumbled by 96,543bps to -3,265.59% in 2025.
  • Its last three reported values are -3,265.59% in Q3 2025, -4,187.73% for Q2 2025, and -7,272.97% during Q1 2025.